Topics Contents of page 2024 2024 June 19, 2024 : Zeria Pharmaceutical and Agastra-Lab announces reaching Agreement for the Development and Market Access of Acotiamide as a Functional Dyspepsia Treatment in Europe, the United States, and Canada (PDF 0.14MB)
